急性肾损伤外展服务预防恶化和死亡试验:一项大型整群随机试验预试验
该研究在两家教学医院开展观察性对照前后对照预试验,干预阶段对干预医院/区域提供工作时间AKI外展服务20周,共纳入1762例成人AKI患者。外展团队在AKI警报后中位15.7小时给出中位3.0条非药物建议和0.5条药物相关建议。探索性分析显示干预医院干预后阶段复合主要结局OR为0.73(95%CI 0.42-1.26;P=0.26)。
要点
- AKI外展服务可在医疗体系内提供标准化专科诊疗。
- 各组合并主要结局(30天死亡或恶化)发生率较低。
- 探索性分析未显示显著获益,OR 0.73(95%CI 0.42-1.26)。
核心结论
- AKI外展服务可为AKI患者提供标准化专科诊疗,但本预试验探索性分析未显示复合主要结局显著改善。
研究设计与样本
- 观察性对照(前)阶段在两家相距9英里的教学医院及其辖区进行;干预(后)阶段在干预医院/区域运行工作时间AKI外展服务20周,另一站点为对照。
- 共纳入1762例成人AKI患者,其中干预站点后阶段744例。
主要发现
- 外展团队在AKI警报后中位15.7小时给出中位3.0条非药物建议和0.5条药物相关建议。
- 四组30天内死亡率为11-15%,需要透析率为0.4-3.7%。
- 探索性分析中,干预医院后阶段复合主要结局OR为0.73(95%CI 0.42-1.26;P=0.26)。
临床怎么用
- AKI外展服务模式可跨医疗体系提供标准化专科建议,但需进一步试验验证临床获益。
- 未来试验可聚焦于预后中等、肾脏干预可能获益最大的AKI患者。
局限性
- 本研究为大型预试验,探索性分析未达统计学显著性。
- 主要结局发生率较低,可能影响试验把握度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The Acute Kidney Outreach to Reduce Deterioration and Death trial was a large pilot study for a cluster-randomized trial of acute kidney injury (AKI) outreach. METHODS: An observational control (before) phase was conducted in two teaching hospitals (9 miles apart) and their respective catchment areas. In the intervention (after) phase, a working-hours AKI outreach service operated for the intervention hospital/area for 20 weeks, with the other site acting as a control. All AKI alerts in both hospital and community patients were screened for inclusion. Major exclusion criteria were patients who were at the end of life, unlikely to benefit from outreach, lacking mental capacity or already referred to the renal team. The intervention arm included a model of escalation of renal care to AKI patients, depending on AKI stage. The 30-day primary outcome was a combination of death, or deterioration, as shown by any need for dialysis or progression in AKI stage. A total of 1762 adult patients were recruited; 744 at the intervention site during the after phase. RESULTS: A median of 3.0 non-medication recommendations and 0.5 medication-related recommendations per patient were made by the outreach team a median of 15.7 h after the AKI alert. Relatively low rates of the primary outcomes of death within 30 days (11-15%) or requirement for dialysis (0.4-3.7%) were seen across all four groups. In an exploratory analysis, at the intervention hospital during the after phase, there was an odds ratio for the combined primary outcome of 0.73 (95% confidence interval 0.42-1.26; P = 0.26). CONCLUSIONS: An AKI outreach service can provide standardized specialist care to those with AKI across a healthcare economy. Trials assessing AKI outreach may benefit from focusing on those patients with 'mid-range' prognosis, where nephrological intervention could have the most impact.
引用
- Thomas ME, Abdelaziz TS, Perkins GD, et al. The Acute Kidney Outreach to Prevent Deterioration and Death trial: a large pilot study for a cluster-randomized trial. Nephrol Dial Transplant. 2021. PMID: 31860096. doi:10.1093/ndt/gfz246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。